You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
Northbrook, Ill. – Sept. 7, 2016 - Astellas announces the appointment of Stefanie Prodouz and Agatha Newman, who have joined Astellas as associate directors supporting communications for the company’s Medical & Development team.
“As we broaden Astellas’ communication efforts around the world, Stefanie and Agatha bring a wealth of knowledge and experience to our growing team,” said Jeff Winton, senior vice president, Corporate Affairs. “Both will help expand Astellas’ vision to be on the forefront of healthcare innovation for patients.”
In her role, Prodouz will take on primary responsibility for external communications in support of the Medical & Development (M&D) organization and its leadership globally, including media relations and executive visibility efforts. Most recently, she held positions in investor relations and public affairs at AbbVie. Prodouz is a graduate of Purdue University in West Lafayette, Ind. in Communications with a minor in Business and Organizational Leadership.
In her role, Newman will take on primary responsibility for internal communications in support of the M&D organization and its leadership globally, including leading development of a scientific and research-focused content strategy. Most recently, Newman held positions in corporate communications and global public affairs at AbbVie. Newman graduated magna cum laude from Saint Louis University in St. Louis, Missouri and holds a B.A. in Communication with a certificate in Marketing.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.